Danish govt allocates over 3 billion kroner to better conditions for entrepreneurs

"There is a need for good conditions for entrepreneurs in Denmark. It is an important piece if we hope to maintain and expand our global position, not least within life science and biotech," says Ida Sofie Jensen, chief executive of the Danish Pharmaceutical Industry Association, Lif.

She is therefore pleased that the government has just announced that it will spend 2.1 billion kroner (~$300 million) in 2024-2026 and 1.1 billion kroner annually from 2027 on better conditions for entrepreneurs, including less bureaucracy, tax breaks and better opportunities to attract talent as well as by removing the maligned phantom tax.

"With the strategy, steps are taken to strengthen the conditions for investing in promising new ideas and breakthroughs. It is absolutely central to the Danish biotech ecosystem and strengthens Denmark's opportunities in the global competition for attracting capital and investments," she says and continues: "In this connection, it is positive that the strategy also sets out to target efforts towards the Danish positions of strength, such as life science, for example."